Bluebird Bio | Ventas

Sales Cambio Fecha
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Arrowhead Research USD 3.55M 12.55M 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Moderna USD 2.81B 980M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Bluebird Bio Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.